About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 7,371–7,380 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 7,030 |
PEDIATRIC BLOOD & CANCER PEDIATR BLOOD CANCER |
1545-5009 1545-5017 |
2.300 | 2.800 | Q2 | 49/191 | WILEY |
| 7,030 |
PEDIATRIC PULMONOLOGY PEDIATR PULM |
8755-6863 1099-0496 |
2.300 | 2.500 | Q2 | 49/191 | WILEY |
| 7,030 |
PEDIATRIC RADIOLOGY PEDIATR RADIOL |
0301-0449 1432-1998 |
2.300 | 2.400 | Q2 | 49/191 | SPRINGER |
| 7,030 |
Pediatric Rheumatology PEDIATR RHEUMATOL |
N/A 1546-0096 |
2.300 | 2.700 | Q2 | 49/191 | BMC |
| 7,030 |
PET Clinics PET CLIN |
1556-8598 1559-7814 |
2.300 | 2.600 | Q2 | 92/212 | ELSEVIER INC |
| 7,030 |
Pharmacology Research & Perspectives PHARMACOL RES PERSPE |
2052-1707 2052-1707 |
2.300 | 2.800 | Q3 | 202/352 | JOHN WILEY & SONS LTD |
| 7,030 |
Philosophical Perspectives PHILOS PERSPECT |
1520-8583 1758-2245 |
2.300 | 2.400 | N/A | N/A | WILEY |
| 7,030 |
Photochem PHOTOCHEM-BASEL |
N/A 2673-7256 |
2.300 | 2.700 | Q3 | 136/185 | MDPI |
| 7,030 |
Physiologia PHYSIOLOGIA-BASEL |
N/A 2673-9488 |
2.300 | 2.300 | Q2 | 42/87 | MDPI |
| 7,030 |
Physiology International PHYSIOL INT |
2498-602X 2498-602X |
2.300 | 1.900 | Q2 | 42/87 | AKADEMIAI KIADO ZRT |